| Identification | Back Directory | [Name]
1(2H)-Phthalazinone, 4-[(4-chlorophenyl)methyl]-2-[[(2R)-1-[4-[4-[3-(hexahydro-1H-azepin-1-yl)propoxy]phenyl]butyl]-2-pyrrolidinyl]methyl]- | [CAS]
955359-72-5 | [Synonyms]
GSK1004723
GSK-1004723
GSK 1004723
1(2H)-Phthalazinone, 4-[(4-chlorophenyl)methyl]-2-[[(2R)-1-[4-[4-[3-(hexahydro-1H-azepin-1-yl)propoxy]phenyl]butyl]-2-pyrrolidinyl]methyl]- | [Molecular Formula]
C39H49ClN4O2 | [MOL File]
955359-72-5.mol | [Molecular Weight]
641.28 |
| Hazard Information | Back Directory | [Uses]
GSK-1004723 is a novel H1/H3 receptor antagonist with limited activity for the suppression of seasonal allergic rhinitis. GSK-1004723 is available as a suspension or solution for intranasal administration. | [References]
[1] The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis DOI:10.1159/000329738 |
|
|